Executive Management

Jacqui was promoted to Chief Corporate Affairs Officer in March 2025. She oversees investor relations, corporate communications, patient engagement, and government affairs and policy. With over 20 years of experience in biopharmaceuticals and public affairs, Jacqueline joined Crinetics in 2023 after serving as Vice President of Global Corporate Affairs at Jazz Pharmaceuticals. Prior to her tenure at Jazz, she held several senior positions years at AstraZeneca Pharmaceuticals, including roles in commercial leadership and as Vice President of U.S. Government Affairs. Jacqui earned a bachelor’s degree in political science from Boston University and a master’s degree in liberal arts-political science from Harvard University.